Refine
Document Type
- Article (3)
- Other (1)
- Part of Periodical (1)
Is part of the Bibliography
- yes (5)
Keywords
- kidney cancer (1)
- metabolism (1)
- metabolomics (1)
- metastasis (1)
The Schwarzenberg mining district in the western Erzgebirge hosts numerous skarn-hosted tin-polymetallic deposits, such as Breitenbrunn. The St. Christoph mine is located in the Breitenbrunn deposit and is the locus typicus of christophite, an iron-rich sphalerite variety, which can be associated with indium enrichment. This study presents a revision of the paragenetic scheme, a contribution to the indium behavior and potential, and discussion on the origin of the sulfur. This was achieved through reflected light microscopy, SEM-based MLA, EPMA, and bulk mineral sulfur isotope analysis on 37 sulfide-rich skarn samples from a mineral collection. The paragenetic scheme includes: a pre-mineralization stage of anhydrous calc-silicates and hydrous minerals; an oxide stage, dominated by magnetite; a sulfide stage of predominantly sphalerite, minor pyrite, chalcopyrite, arsenopyrite, and galena. Some sphalerite samples present elevated indium contents of up to 0.44 wt%. Elevated iron contents (4-10 wt%) in sphalerite can be tentatively linked to increased indium incorporation, but further analyses are required. Analyzed sulfides exhibit homogeneous delta S-34 values (-1 to +2 parts per thousand VCDT), assumed to be post-magmatic. They correlate with other Fe-Sn-Zn-Cu-In skarn deposits in the western Erzgebirge, and Permian vein-hosted associations throughout the Erzgebirge region.
The hormone calcitonin (CT) is primarily known for its pharmacologic action as an inhibitor of bone resorption, yet CT-deficient mice display increased bone formation. These findings raised the question about the underlying cellular and molecular mechanism of CT action. Here we show that either ubiquitous or osteoclast-specific inactivation of the murine CT receptor (CTR) causes increased bone formation. CT negatively regulates the osteoclast expression of Spns2 gene, which encodes a transporter for the signalling lipid sphingosine 1-phosphate (S1P). CTR-deficient mice show increased S1P levels, and their skeletal phenotype is normalized by deletion of the S1P receptor S1P(3). Finally, pharmacologic treatment with the nonselective S1P receptor agonist FTY720 causes increased bone formation in wild-type, but not in S1P(3)-deficient mice. This study redefines the role of CT in skeletal biology, confirms that S1P acts as an osteoanabolic molecule in vivo and provides evidence for a pharmacologically exploitable crosstalk between osteoclasts and osteoblasts.
Recent evidence suggests that metabolic changes play a pivotal role in the biology of cancer and in particular renal cell carcinoma (RCC). Here, a global metabolite profiling approach was applied to characterize the metabolite pool of RCC and normal renal tissue. Advanced decision tree models were applied to characterize the metabolic signature of RCC and to explore features of metastasized tumours. The findings were validated in a second independent dataset. Vitamin E derivates and metabolites of glucose, fatty acid, and inositol phosphate metabolism determined the metabolic profile of RCC. alpha-tocopherol, hippuric acid, myoinositol, fructose-1-phosphate and glucose-1-phosphate contributed most to the tumour/normal discrimination and all showed pronounced concentration changes in RCC. The identified metabolic profile was characterized by a low recognition error of only 5% for tumour versus normal samples. Data on metastasized tumours suggested a key role for metabolic pathways involving arachidonic acid, free fatty acids, proline, uracil and the tricarboxylic acid cycle. These results illustrate the potential of mass spectroscopy based metabolomics in conjunction with sophisticated data analysis methods to uncover the metabolic phenotype of cancer. Differentially regulated metabolites, such as vitamin E compounds, hippuric acid and myoinositol, provide leads for the characterization of novel pathways in RCC.
We investigated the systems response of metabolism and growth after an increase in irradiance in the nonsaturating range in the algal model Chlamydomonas reinhardtii. In a three-step process, photosynthesis and the levels of metabolites increased immediately, growth increased after 10 to 15 min, and transcript and protein abundance responded by 40 and 120 to 240 min, respectively. In the first phase, starch and metabolites provided a transient buffer for carbon until growth increased. This uncouples photosynthesis from growth in a fluctuating light environment. In the first and second phases, rising metabolite levels and increased polysome loading drove an increase in fluxes. Most Calvin-Benson cycle (CBC) enzymes were substrate-limited in vivo, and strikingly, many were present at higher concentrations than their substrates, explaining how rising metabolite levels stimulate CBC flux. Rubisco, fructose-1,6-biosphosphatase, and seduheptulose-1,7-bisphosphatase were close to substrate saturation in vivo, and flux was increased by posttranslational activation. In the third phase, changes in abundance of particular proteins, including increases in plastidial ATP synthase and some CBC enzymes, relieved potential bottlenecks and readjusted protein allocation between different processes. Despite reasonable overall agreement between changes in transcript and protein abundance (R-2 = 0.24), many proteins, including those in photosynthesis, changed independently of transcript abundance.